技术与方法 |
|
|
|
|
中国林蛙卵核糖核酸酶的分离纯化及其抗肿瘤作用 |
陶凤云1,2,赵伟2**,林强2,马润宇1 |
1.北京化工大学生命科学与技术学院 北京 100029
2.北京联合大学生物化学工程学院 北京 100023 |
|
A Cytotoxic Ribonuclease Isolated from Occytes of Chinese Northeast Frog(Rana dybowskii) |
TAO Feng-yun1,2,ZHAO Wei2,LIN Qiang2,MA Run-yu1 |
1.College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029,China
2.Biochemical Engineering College, Beijing Union University , Beijing 100023,China |
[1] Beck A K, Pass H I, Carbone M, et al. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncol, 2008, 4(3):341349.
[2] Matousek J. Ribonucleases and their antitumor activity. Com PBiochem Physiol C Toxicol Pharmacol, 2001,129 (3):175191.
[3] Dickson K A, Haigis M C, Raines R T. Ribonuclease inhibitor: structure and function. Prog Nucleic Acid Res Mol Biol, 2005,80:349374.
[4] Ardelt W, Mikulski S M, Shogen K. Amino acid sequence of an antitumor protein from Rana pipiens oocytes and early embryos. Homology to pancreatic ribonucleases. J Biol Chem, 1991,266 (1):245251.
[5] Rutkoski T J, Raines R T. Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity. Curr Pharm Biotechnol, 2008 ,9(3):185189.
[6] Ardelt W, Shogen K, Darzynkiewicz Z. Onconase and amphinase, the antitumor ribonucleases from Rana pipiens oocytes. Curr Pharm Biotechnol, 2008, 9(3):215225.
[7] Liao Y D. A pyrimidineguanine sequencespecific ribonuclease from Rana catesbeiana (bullfrog) oocytes. Nucleic Acids Res, 1992, 20 (6):13711377.
[8] Kamiya Y, Oyama F, Oyama R, et al. Amino acid sequence of a lectin from Japanese frog (Rana japonica) eggs. J Biochem, 1990,108 (1):139143.
[9] Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of proteindye binding. Anal Biochem , 1976, 72: 248254.
[10] Rosenberg H F. Recombinant human eosinophil cationic protein.Ribonuclease activity is not essential for cytotoxicity. J Biol Chem, 1995, 270(14):78767881.
[11] Laemmli U K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 1970, 227(5259): 680685.
[12] Lee J E, Raines R T. Ribonucleases as novel chemotherapeutics : the ranpirnase example. BioDrugs , 2008, 22 (1):5358.
[13] Lu C X, Nan K J, Lei Y. Agents from amphibians with anticancer properties. Anticancer Drugs, 2008, 19 (10):931939.
[14] Michaelis M, Cinatl J, Anand P, et al. Onconase induces caspaseindependent cell death in chemoresistant neuroblastoma cells. Cancer Lett, 2007, 250 (1):107116.
[15] Rybak S M, Pearson J W, Fogler W E, et al. Enhancement of vincristine cytotoxicity in drugresistant cells by simultaneous treatment with onconase, an antitumor ribonuclease. J Natl Cancer Inst, 1996, 88 (11):747753.
[16] Zhao W, KoteJarai Z, van Santen Y, et al. Ribonucleases from rat and bovine liver: purification, specificity and structural characterization. Biochim Biophys Acta , 1998, 1384 (1):5565.
[17] Liao Y D, Huang H C, Leu Y J, et al. Purification and cloning of cytotoxic ribonucleases from Rana catesbeiana (bullfrog). Nucleic Acids Res, 2000, 28 (21):40974104.
[18] Zhao H, Ardelt B, Ardelt W, et al. The cytotoxic ribonuclease onconase targets RNA interference (siRNA). Cell Cycle , 2008, 7 (20):32583261.
[19] Ita M, Halicka H D, Tanaka T, et al. Remarkable enhancement of cytotoxicity of onconase and cepharanthine when used in combination on various tumor cell lines. Cancer Biol Ther, 2008, 7 (7):11041108.
[20] RamosNino M E, Littenberg B. A novel combination: ranpirnase and rosiglitazone induce a synergistic apoptotic effect by downregulating Fra1 and Survivin in cancer cells. Mol Cancer Ther, 2008, 7 (7):18711879. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|